Cytokines and Behcet's Disease

Autoimmunity Reviews

Volumn 11, Issue 10, 2012, Pages 699-704

  Zhou, Z Y ^a   Chen, S L ^a   Shen, N ^a,b,c   Lu, Y ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Behcet's Disease; Cytokine target treatment; Pathogenesis

Indexed keywords

ALPHA INTERFERON; CHEMOKINE; CYTOKINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCOCORTICOID; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 23 RECEPTOR B2; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RANTES; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AUTOIMMUNE UVEITIS; BEHCET DISEASE; CYTOKINE RELEASE; DISEASE ACTIVITY; DRUG EFFICACY; GENETIC RISK; GENOTYPE; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; NONHUMAN; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TH1 CELL; TH17 CELL; TH2 CELL;

ALLELES; BEHCET SYNDROME; CYTOKINES; DRUG DELIVERY SYSTEMS; GENOTYPE; HUMANS; INFLAMMATION MEDIATORS; TH1 CELLS; TH17 CELLS;

EID: 84864389634     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.12.005     Document Type: Review

References (58)

1. Yazici H. The lumps and bumps of Behçet's syndrome. Autoimmun Rev 2004, 3:S53-S54. (Jun).
2. Novak J., Lehuen A. Mechanism of regulation of autoimmunity by iNKT cells. Cytokine 2011, 53:263-270.
3. Lee K.H., Chung H.S., Kim H.S. Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease. Arthritis Rheum 2003, 48:2025-2035.
4. Lu Y., Ye P., Chen S.L., et al. Identification of kinectin as a novel Behçet's disease autoantigen. Arthritis Res Ther 2005, 7:1133-1139.
5. Engel P., Gómez-Puerta J.A., Ramos-Casals M., et al. Therapeutic targeting of B cells for rheumatic autoimmune diseases. Pharmacol Rev 2011, 63:127-156.
6. Ling E., Shubinsky G., Press J. Increased proportion of CD3+CD4-CD8- double-negative T cells in peripheral blood of children with Behcet's disease. Autoimmun Rev 2007, 6:237-240.
7. Hamzaoui K., Hamaz M., Ayed K. Production of TNF-alpha and IL-1 in active Behçet's disease. J Rheumatol 1990, 17:1428-1429.
8. Pay Salih, Erdem Hakan, Pekel Aysel, et al. Synovial proinflammatory cytokines and their correlation with matrixmetalloproteinase-3 expression in Behçet's disease. Does interleukin-1b play a major role in Behçet's synovitis?. Rheumatol Int 2006, 27:608-613.
9. Karasneh J., Hajeer A.H., Barrett J., et al. Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet's disease. Rheumatology 2003, 42:860-864. (Oxford).
10. Akman Ayse, Ekinci Nilufer Cicek, Kacaroglu Hasan, et al. Relationship between periodontal findings and specific polymorphisms of interleukin-1 and -1 in Turkish patients with Behçet's disease. Arch Dermatol Res 2008, 300:19-26.
11. Coskun M., Bacanli A., Sallakci N., et al. Specific interleukin-1 gene polymorphisms in Turkish patients with Behcet's disease. Exp Dermatol 2005, 14:124-129.
12. Botsios C., Sfriso P., Furlan A., et al. Resistant Behçet disease responsive to anakinra. Ann Intern Med 2008, 19:284-286.
13. Touma Zahi, Farra Chantal, Hamdan Ayad, et al. TNF polymorphisms in patients with Behçet disease: a meta-analysis. Arch Med Res 2010, 41:142-146.
14. Commodaro A.G., Bueno V., Belfort R., et al. Autoimmune uveitis: the associated proinflammatory molecules and the search for immunoregulation. Autoimmun Rev 2011, 10:205-209.
15. Kikuchi H., Aramaki K., Hirohata S. Effect of infliximab in progressive neuro-Behçet's syndrome. J Neurol Sci 2008, 272:99-105.
16. Midori Misumi, Eri Hagiwara, Mitsuhiro Takeno, et al. Cytokine production profile in patients with Behcet's disease treated with infliximab; 24 (2003) pp. 210-218.
17. Akdeniz N., Esrefoglu M., Keleş M.S., et al. Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease. Ann Acad Med Singapore 2004, 33:596-599.
18. Adam B., Calikoglu E. Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Behçet's disease. J Eur Acad Dermatol Venereol 2004, 18:318-320.
19. Nalbant S., Sahan B., Durna M., et al. Cytokine profile in Behçet uveitis. Bratisl Lek Listy 2008, 109:551-554.
20. Wang C.R., Chuang C.Y., Chen C.Y. Anticardiolipin antibodies and interleukin-6 in cerebrospinal fluid and blood of Chinese patients with neuro-Behçet's syndrome. Clin Exp Rheumatol 1992, 10:599-602.
21. Akman-Demir G., Tüzün E., Içöz S., et al. Interleukin-6 in neuro-Behçet's disease: association with disease subsets and long-term outcome. Cytokine 2008, 44:373-376.
22. Central Hirohata S. Nervous system involvement in Behçet's disease. Rinsho Shinkeigaku 2001, 41:1147-1149.
23. Borhani Haghighi A., Safari A. Tocilizumab may be a potential addition to our weapons against neuro-Behçet's disease. Med Hypotheses 2008, 71:156-157.
24. Bowcock A.M., Ray A., Erlich H., Sehgal P.B. Rapid detection and sequencing of alleles in the 3' flanking region of the interleukin-6 gene. Nucleic Acids Res 1989, 17:6855-6864.
25. Chang H.K., Jang W.C., Park S.B., et al. Association between interleukin 6 gene polymorphisms and Behcet's disease in Korean people. Ann Rheum Dis 2005, 64:339-340.
26. Guenane H., Hartani D., Chachoua L., et al. Production of Th1/Th2 cytokines and nitric oxide in Behçet's uveitis and idiopathic uveitis. J Fr Ophtalmol 2006, 29:146-152.
27. Belguendouz H., Messaoudene D., Hartani D., et al. Effect of corticotherapy on interleukin-8 and -12 and nitric oxide production during Behçet and idiopathic uveitis. J Fr Ophtalmol 2008, 31:387-395.
28. Ahn J.K., Yu H.G., Chung H., Park Y.G. Intraocular cytokine environment in active Behçet uveitis. Am J Ophthalmol 2006, 142:429-434.
29. Alayli G., Aydin F., Coban A.Y., Süllü Y., et al. T helper 1 type cytokines polymorphisms: association with susceptibility to Behçet's disease. Clin Rheumatol 2007, 26:1299-1305.
30. Remmers E.F., Cosan F., Kirino Y., et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat Genet 2010, 42:698-702.
31. Mizuki N., Meguro A., Ota M., et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat Genet 2010, 42:703-706.
32. Mendoza-Pinto C., García-Carrasco M., Jiménez-Hernández M. Etiopathogenesis of Behcet's disease. Autoimmun Rev 2010, 9:241-245.
33. Oztas M.O., Onder M., Gurer M.A., et al. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease. Clin Exp Dermatol 2005, 30:61-63.
34. Musabak U., Pay S., Erdem H., Simsek I., et al. Serum interleukin-18 levels in patients with Behçet's disease. Is its expression associated with disease activity or clinical presentations?. Rheumatol Int 2006, 26:545-550.
35. Jang W.C., Park S.B., Nam Y.H., et al. Interleukin-18 gene polymorphisms in Korean patients with Behçet's disease. Clin Exp Rheumatol 2005, 23:S59-S63.
36. Lee Y.J., Kang S.W., Park J.J. Interleukin-18 promoter polymorphisms in patients with Behçet's disease. Hum Immunol 2006, 67:812-818.
37. Ben Ahmed M., Houman H., Miled M., et al. Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease. Arthritis Rheum 2004, 50:2291-2295.
38. Belguendouz H., Messaoudène D., Lahmar K., et al. Interferon-γ and nitric oxide production during Behçet uveitis: immunomodulatory effect of interleukin-10. J Interferon Cytokine Res 2011, 21. [Epub ahead of print].
39. Wallace G.R., Kondeatis E., Vaughan R.W., et al. IL-10 genotype analysis in patients with Behçet's disease. Hum Immunol 2007, 68:122-127.
40. Ateş O., Dalyan L., Hatemi G., et al. Analyses of functional IL10 and TNF-α genotypes in Behçet's syndrome. Mol Biol Rep 2010, 37:3637-3641.
41. Nicolas Manel. In vitro differentiation of human Th-17 CD4+ T cells. Protocol Exchange. 2008 published online.
42. Hamzaoui K., Hamzaoui A., Guemira F., et al. Cytokine profile in Behçet's disease patients, relationship with disease activity. Scand J Rheumatol 2002, 31:205-210.
43. Chi W., Yang P., Zhu X., et al. Production of interleukin-17 in Behcet's disease is inhibited by cyclosporin A. Mol Vis 2010, 19:880-886.
44. Chi W., Zhou S., Yang P., et al. CD4+ T cells from Behcet patients produce high levels of IL-17. Yan Ke Xue Bao 2011, 26:6-13.
45. Jiang Z., Yang P., Hou S. IL-23R gene confers susceptibility to Behcet's disease in a Chinese Han population. Ann Rheum Dis 2010, 69:1325-1328.
46. Hamzaoui K., Bouali E., Ghorbel I. Expression of Th-17 and RORγt mRNA in Behçet's Disease. Med Sci Monit 2011, 17:CR227-CR234.
47. Usui Y., Takeuchi M., Yamakawa N., et al. Expression and function of inducible costimulator on peripheral blood CD4+ T cells in Behçet's patients with uveitis: a new activity marker?. Invest Ophthalmol Vis Sci 2010, 51:5099-5104.
48. Jang W.C., Nam Y.H., Ahn Y.C., et al. Interleukin-17F gene polymorphisms in Korean patients with Behçet's disease. Rheumatol Int 2008, 29:173-178.
49. Gür-Toy G., Lenk N., Yalcin B. Serum interleukin-8 as a serologic marker of activity in Behçet's disease. Int J Dermatol 2005, 44:657-660.
50. Durmazlar S.P., Ulkar G.B., Eskioglu F., et al. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement. Int J Dermatol 2009, 48:259-264.
51. Lee E.B., Kim J.Y., Zhao J., et al. Haplotype association of IL-8 gene with Behcet's disease. Tissue Antigens 2007, 69:128-132.
52. Duymaz-Tozkir J., Yilmaz V., Uyar F.A., et al. Polymorphisms of the IL-8 and CXCR2 genes are not associated with Behçet's disease. J Rheumatol 2005, 32:93-97.
53. Storz K., Löffler J., Koch S. IL-6 receptor, IL-8 receptor and TNF-alpha238 (G/A) polymorphisms are not associated with Behçet's disease in patients of German or Turkish origin. Clin Exp Rheumatol 2008, 26:S103-S106.
54. Saruhan-Direskeneli G., Yentür S.P., Akman-Demir G., et al. Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases. J Neuroimmunol 2003, 145:127-134.
55. Kim W.U., Do J.H., Park K.S., et al. Enhanced production of macrophage inhibitory protein-1alpha in patients with Behçet's disease. Scand J Rheumatol 2005, 34:129-135.
56. Chen Y., Vaughan R.W., Kondeatis E., et al. Chemokine gene polymorphisms associate with gender in patients with uveitis. Tissue 2004, 63:41-45.
57. El-Asrar A.M., Struyf S., Kangave D., et al. Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Clin Immunol 2011, 139:177-184.
58. Langier S., Sade K., Kivity S. Regulatory T cells: the suppressor arm of the immune system. Autoimmun Rev 2010, 10:112-115.